Registrations are now open for a webinar focusing on “Clinical considerations when starting Hybrid Closed-Loop therapy
Led by Geraldine Gallen, a Senior Diabetes Specialist Nurse, Kings College Hospital, London, the session will be held on May 21 at 1pm.
Hybrid Closed-Loop (HCL) therapy has transformed diabetes management, but successful adoption relies on a well-structured on-boarding process. This expert-led webinar will explore the critical steps in ensuring people living with diabetes achieve optimal glycaemic control while gaining confidence in using the technology.
Key topics include:
· Pre-Assessments: Selecting the right system, assessing psychological readiness, and addressing complex clinical needs.
· Essential education and optimisation: Building a strong foundation with system settings tailored to individual needs.
· Ongoing support: Enhancing self-management skills, leveraging peer support, and optimising service capacity.
Don't miss this opportunity to refine your approach to HCL initiation and support.
We have received funding by means of sponsorship to support the delivery of this webinar. Our sponsors have had no editorial input or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentation.
Information contained herein is not medical advice and should not be used as an alternative to speaking with your doctor. Discuss indications, contraindications, warnings, precautions, potential adverse events and any further information with your health care professional. Please consult your healthcare professional for a full list of benefits, indications, precautions, clinical results, and other important medical information that pertains to the therapy or products discussed. See the device manuals for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative.